ArticleFrontiers in oncology2026

Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.

Yulu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.